International safety notice
Safety Notice for the contrast media injector system OptiVantage™ DH, Mallinckrodt Pharmaceuticals
Germany / BfArM · DEU · Apr 9, 2014
Key facts
| Title | Safety Notice for the contrast media injector system OptiVantage™ DH, Mallinckrodt Pharmaceuticals |
|---|---|
| Regulator | Germany / BfArM |
| Country | DEU |
| Brand | the contrast media injector system OptiVantage™ DH, Mallinckrodt Pharmaceuticals |
| Manufacturer | Safety Notice for the contrast media injector system OptiVantage™ DH, Mallinckrodt Pharmaceuticals |
| Models | SLE4EOPREVENT, 001-314-654-5737, 846001, 63042, 4.1.1, 314.654.2000 |
| Date | Apr 9, 2014 |
| Regulator page | bfarm.de |
At a glance
- No Recall
- No Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1